Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Research output: Contribution to journal › Article › peer-review

Authors

Colleges, School and Institutes

Details

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Publication statusAccepted/In press - Apr 2020
Save citation Saved citations (0)

Copy the text from this field...

View graph of relations

By the same authors

Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)

Lorraine Harper, 9 Jan 2021, In: Rheumatology.

Research output: Contribution to journal › Article › peer-review